PL374656A1 - Combinations of atorvastatin and alpha1, adrenergic receptor antagonists - Google Patents
Combinations of atorvastatin and alpha1, adrenergic receptor antagonistsInfo
- Publication number
- PL374656A1 PL374656A1 PL03374656A PL37465603A PL374656A1 PL 374656 A1 PL374656 A1 PL 374656A1 PL 03374656 A PL03374656 A PL 03374656A PL 37465603 A PL37465603 A PL 37465603A PL 374656 A1 PL374656 A1 PL 374656A1
- Authority
- PL
- Poland
- Prior art keywords
- alpha1
- atorvastatin
- combinations
- receptor antagonists
- adrenergic receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0221579.6A GB0221579D0 (en) | 2002-09-17 | 2002-09-17 | Combinations of atorvastatin and, adrenergic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
PL374656A1 true PL374656A1 (en) | 2005-10-31 |
Family
ID=9944250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03374656A PL374656A1 (en) | 2002-09-17 | 2003-09-05 | Combinations of atorvastatin and alpha1, adrenergic receptor antagonists |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1542677A1 (en) |
CN (1) | CN1681492A (en) |
AU (1) | AU2003263420A1 (en) |
BR (1) | BR0314388A (en) |
CA (1) | CA2498894A1 (en) |
GB (1) | GB0221579D0 (en) |
PL (1) | PL374656A1 (en) |
TW (1) | TW200407123A (en) |
WO (1) | WO2004026300A1 (en) |
ZA (1) | ZA200502225B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100418529C (en) * | 2006-06-30 | 2008-09-17 | 南京美瑞制药有限公司 | Application of Nepider in preparing medicine to accelerate ejection of calculus for urinary system |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1238011B (en) * | 1989-12-13 | 1993-06-21 | Pulitzer Italiana | Pharmaceutical composition with an HMG - COA reductase inhibitor base, for treatment of benign prostatic hypertrophy (enlarged prostate gland) |
GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
GT199800126A (en) * | 1997-08-29 | 2000-01-29 | COMBINATION THERAPY. | |
US6534537B2 (en) * | 2000-01-07 | 2003-03-18 | Kenneth Weisman | Use of HMG-COA reductase inhibitors to prevent and treat BPH |
GB0206033D0 (en) * | 2002-03-14 | 2002-04-24 | Pfizer Ltd | Compounds useful in therapy |
-
2002
- 2002-09-17 GB GBGB0221579.6A patent/GB0221579D0/en not_active Ceased
-
2003
- 2003-09-05 BR BR0314388-0A patent/BR0314388A/en not_active Application Discontinuation
- 2003-09-05 CN CNA038217864A patent/CN1681492A/en active Pending
- 2003-09-05 PL PL03374656A patent/PL374656A1/en not_active Application Discontinuation
- 2003-09-05 CA CA002498894A patent/CA2498894A1/en not_active Abandoned
- 2003-09-05 WO PCT/IB2003/003940 patent/WO2004026300A1/en not_active Application Discontinuation
- 2003-09-05 EP EP03797447A patent/EP1542677A1/en not_active Withdrawn
- 2003-09-05 AU AU2003263420A patent/AU2003263420A1/en not_active Abandoned
- 2003-09-16 TW TW092125472A patent/TW200407123A/en unknown
-
2005
- 2005-03-16 ZA ZA200502225A patent/ZA200502225B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004026300A1 (en) | 2004-04-01 |
AU2003263420A1 (en) | 2004-04-08 |
CA2498894A1 (en) | 2004-04-01 |
CN1681492A (en) | 2005-10-12 |
TW200407123A (en) | 2004-05-16 |
EP1542677A1 (en) | 2005-06-22 |
BR0314388A (en) | 2005-07-19 |
GB0221579D0 (en) | 2002-10-23 |
ZA200502225B (en) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003261392A8 (en) | M3muscarinic acetylcholine receptor antagonists | |
IL165280A0 (en) | 4-Substituted imidazole-2-thiones and imidazol-2-ones as agpmosts of the alpha-2b and alpha-2c adrenergic receptors | |
IL165841A0 (en) | Mchir antagonists | |
HK1090922A1 (en) | Cgrp receptor antagonists cgrp | |
HK1083188A1 (en) | Diaryl ethers as opioid receptor antagonists | |
EP1553075A4 (en) | Lpa receptor antagonists | |
IL162825A0 (en) | Fluoro substituted cycloalkanoindoles and their use asprotaglandin d2 receptor antagonists | |
EP1351933A4 (en) | Il-8 receptor antagonists | |
PL376509A1 (en) | Antagonists il-15 | |
AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
IL160942A0 (en) | Compounds having partial dopamine-d2 receptor agonist plus serotonin and/or noradrenaline inhibitor activity | |
PL378753A1 (en) | Ccr-3 receptor antagonists | |
IL163939A0 (en) | Nk1 antagonists | |
IL164016A0 (en) | Azetidine derivatives as ccr-3 receptor antagonists | |
IL165727A0 (en) | Chemokine antagonists | |
AU2003260072A8 (en) | Antagonists of chemokine receptors | |
AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
AU2003287219A8 (en) | Il-8 receptor antagonists | |
AU2002359524A8 (en) | P2x7 receptor antagonists | |
GB0203412D0 (en) | 5-HT 2B receptor antagonists | |
PL374656A1 (en) | Combinations of atorvastatin and alpha1, adrenergic receptor antagonists | |
GB0101223D0 (en) | Histamine receptor antagonists | |
AU2003223329A8 (en) | Antagonists of rf-amide neuropeptides | |
IL158063A0 (en) | Crf receptor antagonists | |
GB0215389D0 (en) | Receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |